Endometrial Cancer Trial, Recruiting NCT07431788 Sponsor: Erkan Gol Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT07431788
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 18 or older
  • You are scheduled to have your womb removed through an abdominal operation (called a total abdominal hysterectomy) for a non-cancer-related reason
  • You have been sexually active in the last 4 weeks
  • You are able to fill in a specific questionnaire about sexual function (called the FSFI)
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You have been diagnosed with a gynaecological cancer (such as cancer of the womb, ovaries, or cervix)
  • You are also having a major additional pelvic surgery at the same time (confirm with trial site)
  • You have a serious mental health or neurological condition
  • You are unable to attend or complete follow-up appointments and assessments after the initial treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erkan Göl, MD, University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey

Phone: +905398517917

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Erkan Gol
Registry
ClinicalTrials.gov
Start date
2 March 2026
Est. completion
1 February 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

3-Month Postoperative Female Sexual Function Index Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov